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Abstract
Acute moderate hypoxic exposure can substantially impair exercise performance, which occurs with a concurrent exacerbated 
rise in hydrogen cation  (H+) production. The purpose of this study was therefore, to alleviate this acidic stress through sodium 
bicarbonate  (NaHCO3) supplementation and determine the corresponding effects on severe-intensity intermittent exercise 
performance. Eleven recreationally active individuals participated in this randomised, double-blind, crossover study per-
formed under acute normobaric hypoxic conditions  (FiO2% = 14.5%). Pre-experimental trials involved the determination of 
time to attain peak bicarbonate anion concentrations  ([HCO3−]) following  NaHCO3 ingestion. The intermittent exercise tests 
involved repeated 60-s work in their severe-intensity domain and 30-s recovery at 20 W to exhaustion. Participants ingested 
either 0.3 g kg bm−1 of  NaHCO3 or a matched placebo of 0.21 g kg bm−1 of sodium chloride prior to exercise. Exercise 
tolerance (+ 110.9 ± 100.6 s; 95% CI 43.3–178 s; g = 1.0) and work performed in the severe-intensity domain (+ 5.8 ± 6.6 kJ; 
95% CI 1.3–9.9 kJ; g = 0.8) were enhanced with  NaHCO3 supplementation. Furthermore, a larger post-exercise blood lactate 
concentration was reported in the experimental group (+ 4 ± 2.4 mmol l−1; 95% CI 2.2–5.9; g = 1.8), while blood  [HCO3−] 
and pH remained elevated in the  NaHCO3 condition throughout experimentation. In conclusion, this study reported a posi-
tive effect of  NaHCO3 under acute moderate hypoxic conditions during intermittent exercise and therefore, may offer an 
ergogenic strategy to mitigate hypoxic induced declines in exercise performance.
Keywords Alkalosis · Altitude · Extreme environments · Intermittent hypoxic exercise · Critical power · Severe-intensity 
domain
Abbreviations
[HCO3−]  Bicarbonate anion concentrations
[lactate]  Blood lactate concentrations
CI  Confidence intervals
CP  Critical power
g  Hedge’s g
H+  Hydrogen cation
V̇O2peak  Peak rate of oxygen consumption
O2  Oxygen
spo2  Oxygen saturation
NaHCO3  Sodium bicarbonate
NaCl  Sodium chloride
VT1  Ventilatory threshold 1
Wʹ  W prime
Introduction
Acute ambient hypoxic environments are often used as 
an ergogenic strategy to enhance exercise-induced train-
ing adaptations (Lundby et al. 2012). Indeed, methods that 
involve interspersed acute hypoxic exercise bouts within a 
training programme, are suggested to augment molecular 
training adaptations leading to enhanced anaerobic glyco-
lytic activity (Faiss et al. 2013). This benefit is not without 
cost however, as the lower availability of oxygen  (O2) may 
elicit an ergolytic effect on exercise intensity and volume 
during intermittent and continuous exercise (Aldous et al. 
2016; Clark et al. 2007). The precise reasons causing these 
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attenuations in exercise performance are ambiguous; how-
ever, an integrated central and peripheral fatigue response is 
likely (Fan and Kayser 2016). This includes a lower convec-
tive  O2 delivery to active skeletal muscle (Amann and Cal-
bet 2008), an exacerbated disturbance to acid–base balance 
during exercise (Hogan et al. 1999; Romer et al. 2007) and 
under severe hypoxic conditions (> 3000 m), a further reduc-
tion in group III/IV afferent feedback to diminish central 
motor output is apparent (Amann et al. 2007). The resultant 
decline in exercise performance presents a challenge to the 
management of training load during acute hypoxic training 
regimes to ensure the acute cost to exercise performance 
does not hamper the potential medium to long-term benefits 
of these strategies.
Acute dietary strategies have previously been used to 
mitigate for the impaired exercise performance caused by 
acute hypoxia. This includes dietary nitrate supplementation 
to enhance convective  O2 delivery (Shannon et al. 2017) 
and sodium bicarbonate  (NaHCO3) supplementation as an 
alkalotic buffer to dampen the elevated acidic stress (Deb 
et al. 2017). The latter presents an interesting physiologi-
cal paradigm, given the relative increase in glycolytic flux 
with hypoxic exposure potentiating hydrogen cation  (H+) 
production. However, their concurrent removal may be hin-
dered as blood bicarbonate buffering capacity may be dimin-
ished under hypoxic conditions, due to a suggested lower 
bicarbonate anion concentrations  ([HCO3−]) (Cerretelli and 
Samaja 2003). It is therefore intuitive to assess ergogenic 
strategies that may facilitate the removal of excess  H+ during 
exercise and compensate for the suggested  [HCO3−] reduc-
tions. Indeed, Deb et al., (2017) reported that the efficacy of 
 NaHCO3 supplementation is enhanced under acute hypoxia 
compared to sea level as the magnitude of improvement was 
greater during high-intensity exercise in acute hypoxic con-
ditions. This should be interpreted with caution however, 
given that previous studies have either reported no benefit 
with  NaHCO3 under acute hypoxic conditions (Saunders 
et al. 2014a; Flinn et al. 2014), or inconsistencies in the over-
all ergogenic response (Froio de Araujo Dias et al. 2015). 
Furthermore, there remains considerable contention on the 
importance of the acid–base balance on fatigue and exercise 
performance, as exercise performance can be maintained 
despite perturbations in acid–base balance (Fitts 2016; West-
erblad 2016). Consequently, further research is required to 
elucidate the importance of the acid–base balance, particu-
larly under acute hypoxic exposures where pre-exercise 
alkalotic manipulation may induce beneficial performance 
outcomes for isolated exercise bouts.
It is evident through viewing blood lactate kinetics dur-
ing exercise, and corresponding disturbances in acid–base 
balance, that the ergogenic effects of  NaHCO3 may only 
arise during exercise intensities at or above the severe-
intensity domain. This cluster of exercise intensities can 
be distinguished by physiological markers defined by the 
second lactate and ventilatory (or otherwise known as the 
respiratory compensation point) thresholds, or critical power 
at the lower boundary, whilst the upper boundary is defined 
as the intensity at the peak rate of oxygen consumption ( V̇
O2peak) (Jones et al. 2010). Within this given intensity range, 
an inexorable rise in lactate occurs and the acid–base bal-
ance becomes substantially perturbed to performance limit-
ing levels (Jones et al. 2007). Indeed, work performed in 
the severe-intensity domain during continuous exercise is 
enhanced with prior  NaHCO3 supplementation (Egger et al. 
2014); however, this is not reflected in exercise tolerance 
during severe-intensity intermittent exercise under hypoxic 
conditions in acclimatised individuals (Kozak-Collins et al. 
1994). The acclimatised participants used in the latter study 
may explain the lack of effect, given altitude acclimatisa-
tion negates the additional acidic load apparent in acclima-
tised individuals under acute hypoxia (West 2007). As the 
ergogenicity of  NaHCO3 is dependent on the magnitude of 
acid–base perturbations, it is hypothesised that  NaHCO3 
supplementation will improve severe-intensity intermittent 
exercise under acute hypoxic conditions.
Method
Eleven recreationally active male volunteers (see Table 1 for 
participant characteristics), with no sustained altitude expo-
sure in the preceding 6 months, participated in this investi-
gation. All participants performed regular physical exercise 
and were also accustomed to repeated high-intensity inter-
mittent cycling exercise. This included eight participants 
that regularly partook in cycling exercise (> 60 km week−1 
and > 7 h week−1), which is in accordance with the train-
ing volume that classifies individuals as trained (De Pauw 
et al. 2015), whilst the remaining three participants per-
formed cycling activity as part of a regular exercise regime 
(≥ 4 h week−1), which represents volume of work that clas-
sifies individuals as recreationally active individuals (De 
Table 1  Participant characteristics
Variables Hypoxia
Age 28 ± 6
Height (cm) 179.9 ± 7.2
Weight (kg) 81.7 ± 11.8
BMI 25.2 ± 2.6
Peak power output (W) 333 ± 46
V̇O2peak (l min−1) 3.3 ± 0.4
Ventilatory threshold 1 (W) 159 ± 27
Critical power (W) 222 ± 33
Wʹ (kJ) 21.3 ± 4.5
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Pauw et al. 2015). Prior to obtaining written consent, par-
ticipants were informed of the purpose, benefits and risks 
of participation. Ethical approval was attained from the 
institutional ethics committee and conducted in accordance 
with the Helsinki Declaration. Participants were instructed 
to refrain from strenuous exercise and alcohol consumption 
in the preceding 24 h before each laboratory visit; while also 
abstaining from caffeine for 12 h. A 24-h dietary recall was 
completed during the initial visit, with participants asked 
to replicate dietary intake for subsequent visits. This was 
confirmed verbally on arrival to each laboratory visit. Par-
ticipants arrived in a 3-h postprandial state and were asked 
to maintain water intake prior to arrival to limit confounding 
nutritional effects on exercise performance.
Experimental design
A randomised, double-blind, crossover experimental design 
was employed with participants attending the laboratory up 
to six separate occasions at the same time of day (± 1 h). 
All exercise trials were a minimum 24 h apart and com-
pleted within a 3-week period. A normobaric environmental 
chamber (Model S016r-7-sp, TISS, Portsmouth, UK) was 
used to recreate ambient hypoxic conditions with a fractional 
inspired  O2 percentage  (FiO2%) of 14.5%; while temperature 
(20 °C) and humidity (40%) was also regulated throughout 
the study. Participants were exposed to hypoxic air 10 min 
prior to exercise to allow equilibrium between atmospheric 
and body  O2 stores (Andreassen and Rees 2005).
During the initial visit, individual blood acid–base 
response to 0.3 g kg−1 body mass of  NaHCO3 supplemen-
tation was established through measuring the time course 
of blood acid–base balance across a 90-min period follow-
ing ingestion (Gough et al. 2017). Sodium bicarbonate was 
administered in 400 ml of chilled water and mixed with 
50 ml of sugar-free cordial (blackcurrant squash, Heritage, 
UK); with the participants asked to consume the supplement 
within a 10-min time period. Fingertip capillary blood sam-
ples (70 µl) were drawn every 10 min for 60 min and then 
every 5 min from 60 to 90 min. Participants remained seated 
during the collection of blood into a capillary tube (Elec-
trolyte balanced heparin clinitube, Radiometer, Denmark). 
Blood samples were analysed for  [HCO3−] using a blood 
gas analyser (Radiometer ABL800, Denmark). The indi-
vidual time taken for peak  [HCO3−] to occur was then used 
for the pre-ingestion timing for subsequent experimental 
exercise trials. This method controls for the intra-individual 
differences in acid–base kinetics following  NaHCO3 sup-
plementation (Jones et al. 2016; Gough et al. 2017) and ena-
bles individuals to exercise at their peak blood  [HCO3−] to 
maximise the  HCO3− buffering potential. This timeframe in 
attaining peak blood  [HCO3−] following  NaHCO3 is shown 
to be reproducible (r = 0.94; p < 0.001) between ingestions 
within participants (Gough et al. 2017) and therefore, repre-
sents a reliable method to administer  NaHCO3.
Following the first visit to establish the timeframe for 
attaining peak  [HCO3−], baseline V̇O2peak and the ventilatory 
threshold 1 (VT1) were determined on the second labora-
tory visit using an incremental RAMP test performed under 
simulated hypoxic conditions  (FiO2% = 14.5%). This was 
followed by familiarisation to the 3-min all-out test after 
30-min recovery from the RAMP test. Subsequently, on 
separate laboratory visits, participants performed the 3-min 
test on a further two occasions under acute hypoxic condi-
tions. However, if a valid test was not completed (described 
in further detail below), participants would repeat the test 
during additional laboratory visits. The final two visits 
involved an exhaustive intermittent exercise test performed 
under two different randomised experimental conditions, 
with the prior ingestion of either 0.3 g kg bm of  NaHCO3 
or placebo containing 0.21 g kg bm of sodium chloride 
(NaCl). The placebo was also mixed in 400 ml of water and 
50 ml of cordial to mask the experimental conditions; while 
the dose of NaCl was chosen as it presents an equimolar 
composition of sodium to 0.3 g kg bm of  NaHCO3, which 
consequently mitigates for the potential ergogenic effects of 
sodium (Mora-Rodriguez and Hamouti 2012).
Determination of V̇O2peak and ventilatory threshold1
The RAMP test commenced with 3-min unloaded pedalling 
into a ramped increase of 1 W s−2, equivalent to 30 W min−1. 
A preferred cadence was selected prior to the test, which 
participants were asked to maintain until volitional exhaus-
tion. The test was terminated when this cadence could no 
longer be maintained within 10 rpm for 10 s, despite strong 
verbal encouragement. Exercise tests were performed on an 
electrically braked ergometer (Lode Excalibur Sport, Gro-
ningen, The Netherlands), with the frame dimensions and 
pedals adjusted to participant preference and replicated for 
all subsequent exercise trials. Breath-by-breath pulmonary 
gas exchange was recorded throughout, and in all subse-
quent trials, using a metabolic analyser (Oxycon, Jaeger, 
Germany). Peak power output (PPO) was defined as the 
greatest power output attained at the termination of the test, 
whilst V̇O2peak was defined as the highest 30 s rolling average 
of V̇O2. Ventilatory threshold 1 (VT1) was estimated using 
the detection of inflection points on gas exchange graphs as 
outlined by Beaver et al. (1986).
Three‑min critical power test
A 3-min test was used to determine critical power (CP) and 
W prime (Wʹ) to inform the work intensity used during the 
subsequent intermittent exercise tests. The protocol repli-
cated the seminal work by Vanhatalo et al. (2007), which 
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involved 3-min unloaded pedalling into an abrupt start of 
the 3-min sprint phase, during which the ergometer instantly 
switched to the linear mode. A 10-s countdown was provided 
to prompt the participants to increase cadence over 120 rpm 
and to enable the attainment of peak power at the start of 
the sprint phase. Visual feedback of cadence was available 
during the test, with participants instructed to maintain the 
highest possible cadence throughout the test; strong verbal 
encouragement was provided for the whole test. The linear 
factor resistance (linear factor = power/cadence2) was estab-
lished using the power output corresponding to 50% of the 
difference between VT1 and PPO during the RAMP test, 
along with the individual preferred cadences used during 
the ramp test. Critical power was calculated on the aver-
age power output during the last 30 s of the test and Wʹ as 
the volume of work (kJ) performed above CP. The test was 
deemed valid when there was no evidence of pacing; in that, 
the end 30-s power output was the lowest recorded through-
out the test. In addition, pulmonary V̇O2 had to reach 95% of 
maximum within 60 s of the sprint phase and be maintained 
without any downward drift for the remainder of the test 
(Jones et al. 2010). If these criteria were not attained, the 
test was repeated.
Intermittent tests
All intermittent tests commenced with 1-min pedalling at 
20 W followed by an abrupt start in to repeated intervals of 
60-s work and 30-s recovery until exhaustion. The intensity 
of the work interval was determined by the intensity pre-
dicted to attain task failure in 4-min  (P4), in accordance with 
the two-parameter CP model (Eq. 1), whilst the recovery 
was set at 20 W:
The use of threshold models to set the work profiles of 
intermittent exercise is suggested to increase the accuracy 
of standardising cardiopulmonary and metabolic response 
to exercise within and between individuals, relative to tradi-
tional percentiles of max heart rate, power output or V̇O2peak 
(Tschakert and Hofmann 2013). The work completed in the 
severe-intensity domain could also be calculated by multi-
plying the time spent above CP by the difference between 
the work intensity and CP.
A pre-established preferred cadence was held throughout 
the intermittent test, with task failure defined as the inability 
to maintain cadence within 60% of the preferred cadence 
(Amman et al. 2008), despite strong verbal encouragement. 
Exercise tolerance was determined as the time, in seconds, 
participants could maintain a cadence < 60% of their pre-
ferred cadence at the required power output; whilst the 
cumulative work performed above CP was defined as the 
work performed in the severe-intensity domain during the 
(1)P4 =
(
W
�∕240
)
+ CP.
intermittent test. Heart rate (Forerunner 15, Garmin, US) 
and oxygen saturation  (SpO2) using a fingertip pulse oxi-
meter  (Autocorr® Digital Pulse Oximeter, BCI, US) were 
recorded at the end of every work stage and reported as a 
test average. Fingertip blood samples were collected prior 
to and within 1 min of exercise termination during intermit-
tent experimental trials, using the methods described earlier. 
Samples were analysed for blood pH and  [HCO3−] (Radi-
ometer ABL800, Denmark), with blood lactate concentra-
tions ([lactate]) assessed using a portable measuring device 
(Lactate Pro 2, Arkray, Japan).
Statistical analysis
The Shapiro–Wilk test provided no evidence to reject the 
hypothesis that all data were normally distributed. A paired 
t test was used to compare the exercise durations, work 
completed in severe-intensity domain, mean heart rate and 
 SpO2. Blood variables, including  [HCO3−],  [H+] and [lac-
tate], were analysed through a two-way (treatment [placebo 
vs.  NaHCO3] ×  time [pre-and post-exercise]) ANOVA. 
Where a significant main effect was found, Bonferroni post 
hoc paired comparisons were determined. Effect sizes and 
their 95% confidence intervals (CI) were calculated using 
Hedge’s g for paired comparisons, with the effects inter-
preted and discussed against effects of the relevant prior 
literature (Thompson 2007). These effect sizes can also be 
interpreted as trivial (< 0.20), small (0.20–0.49), moderate 
(0.50–0.79) or large (≥ 0.80) (Cohen 1988). The Hedge’s g 
correction was used to mitigate positive bias of the Cohen’s 
d effect size when using sample sizes less than 20 (Lakens 
2013). Frequentist inferences were assessed against mean 
difference ± 95% CI between experimental conditions, 
with variances that do not cross the zero-boundary inter-
preted as significant. All descriptive data are presented as 
mean ± standard deviation, unless otherwise stated. Statisti-
cal analysis was performed using open source statistical soft-
ware, R (R Foundation for Statistical Computing, Vienna, 
Austria).
Results
The time taken to reach individual peak blood  [HCO3−] 
ranged from 40 to 90 min with a median of value of 70 min. 
Mean CP and Wʹ were 226 ± 31 W and 20.3 ± 7.0 kJ, respec-
tively. Exercise tolerance during the intermittent test (Fig. 1) 
was significantly greater during the  NaHCO3 treatment 
condition by 14.6 ± 12.5% from 734.3 ± 175.7 s during the 
placebo condition to 845.3 ± 242.4 s under  NaHCO3 experi-
mental conditions (mean difference = 110.9 ± 100.6 s, 95% 
CI 43.3–178.5 s). Similarly, the work done in the severe-
intensity domain was significantly increased by 5.8 ± 6.4 kJ 
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(95% CI 1.3–9.9 kJ), from 41.6 ± 14.7 to 47.2 ± 17.6 kJ in 
the placebo and  NaHCO3 conditions, respectively. Despite 
the positive outcome, an increase in work completed in the 
severe-intensity domain was not consistent across all partici-
pants, with participant 9 experiencing an ergolytic effect and 
participant 2 showing no difference between experimental 
conditions (Fig. 2).
An overall main effect for blood  [HCO3−] was appar-
ent (Fig. 3a), with a significantly greater concentration 
observed with  NaHCO3 compared to placebo prior to 
exercise (6.9 ± 1.9 mmol l−1; 95% CI 5.6–8.1 mmol l−1). 
Blood  [HCO3−] remained elevated in the  NaHCO3 
treatment condition post-exercise compared to pla-
cebo (3.0 ± 2.0  mmol  l−1; 95% CI 1.6–4.3  mmol  l−1), 
despite the larger reduction in  [HCO3−] during exercise 
in the  NaHCO3 condition (− 14.9 ± 2.9 mmol l−1; 95% 
CI − 16.9 to − 13.0  mmol  l−1) compared to placebo 
(− 11.0 ± 2.6 mmol l−1; 95% CI − 12.8 to − 9.3 mmol l−1). 
An equivalent result was found for pH (Fig. 3b), with a 
greater pre-exercise values observed in the  NaHCO3 treat-
ment condition compared to placebo (0.08 ± 0.03; 90% CI 
0.06–0.11); whilst pH also remained elevated following 
exercise (0.09 ± 0.06 95% CI 0.05–0.15). This difference in 
pre- and post-exercise pH was apparent given the similar 
reduction during exercise in the placebo (− 0.21 ± 0.08; 
95% CI − 0.28 to − 0.14) and  NaHCO3 conditions 
(− 0.20 ± 0.08; 95% CI − 0.24 to − 0.15). Post-exercise 
blood [lactate] increased by 4.0 ± 2.4 mmol l−1 (95% CI 
2.2–5.9) from 13.9 ± 4.3 mmol  l−1 during the placebo 
condition compared to 17.9 ± 5.9 mmol l−1 with  NaHCO3 
treatment. There were no significant differences in mean 
heart rate (0.4 ± 4.7  bpm; 95% CI − 3.5 to 4.3  bpm) 
and  SpO2 (0.8 ± 2.3%; 95% CI − 1.1 to 2.7%) between 
conditions.
Fig. 1  Hedge’s g effect size and 95% CI of the effect of  NaHCO3 
treatment against placebo treatment for all outcome variables
Fig. 2  Difference in work complete between  NaHCO3 treatment 
against placebo treatment for all participants. Values greater than zero 
indicate that a greater volume of work was performed with  NaHCO3 
and values lower than zero indicate that less work was performed 
with  NaHCO3 compared to placebo. Dashed line represents mean dif-
ference in work complete and the shaded band shows the ± 95% CI of 
effect between treatments
Fig. 3  Pre- and post-exercise blood  [HCO3−] (a) and blood pH (b) 
during  NaHCO3 and placebo experimental trials. *Significant (95% 
CI) difference to corresponding placebo time point. #Significant (95% 
CI) difference to corresponding pre-exercise time point within the 
same experiment condition
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Discussion
The ergogenicity of  NaHCO3 during intermittent exercise 
has only been demonstrated with work intervals involving 
maximal or supra-maximal intensity (Carr et al. 2011). 
Consequently, this study is the first to report that  NaHCO3 
improves exercise tolerance and work performed during 
intermittent exercise in the severe-intensity domain, whilst 
exposed to acute hypoxic conditions. Furthermore, this 
study demonstrated  NaHCO3 improves severe-intensity 
intermittent exercise performance under acute hypoxic 
conditions. The blood acid–base and [lactate] perturba-
tions during exercise observed in the current study are 
similar to previous investigations (Carr et al. 2011), there-
fore suggesting the ergogenic effects of  NaHCO3 is likely 
to be mediated through the manipulation of acid–base bal-
ance. The current study also adds to the growing body of 
literature that has utilised a methodology to elicit peak 
blood  [HCO3−] at the onset of exercise by accounting 
individual variance in blood acid–base kinetics following 
 NaHCO3 ingestion (Miller et al. 2015; Deb et al. 2017). 
Together, this study demonstrates  NaHCO3 supplementa-
tion prescribed to account for the individual variance in 
time to peak blood  [HCO3−], enhances severe-intensity 
intermittent exercise under acute moderate hypoxic con-
ditions. This therefore may offer an ergogenic strategy 
to improve high-intensity intermittent exercise tolerance 
under acute moderate hypoxic conditions.
This study adds to the paucity of research evaluating 
the effect of  NaHCO3 supplementation on exercise per-
formed in the severe-intensity domain, which have demon-
strated equivocal outcomes (George and MacLaren 1988; 
Egger et al. 2014). Egger et al. (2014) reported a signifi-
cant improvement equivalent to 0.41 Hedge’s g units in 
21 well-trained cyclists; whereas George and MacLaren 
(1988) found no significant effect in seven healthy par-
ticipants. This disparity between studies and the positive 
outcome in the current study, could be explained by a 
dose-dependent effect of  NaHCO3. Given that the cur-
rent study demonstrated positive outcomes with a rela-
tive 0.3 kg−1 body mass dose compared to the 0.2 g kg−1 
body mass administered by George and MacLaren (1988). 
Interestingly, the observed effect on exercise tolerance 
and work done in the severe-intensity domain in current 
study was 2–2.5-fold greater than that previously observed 
during severe-intensity exercise. It is important to high-
light the use of intermittent exercise in the current study 
and continuous exercise in previous research may also 
account for the larger ergogenic effect observed in exer-
cise performance. A proposition that is supported with 
meta-analytic evidence, with Carr et al. (2011) reporting 
greater performance improvements with  NaHCO3 during 
repeated compared to continuous exercise. Nevertheless, 
a hypoxic mediated effect cannot be dismissed, as the effi-
cacy of  NaHCO3 may be greater under acute moderate 
hypoxic conditions (Deb et al. 2017), due to the exacer-
bated acid–base perturbations (Hogan et al. 1999). This 
hypothesis should, however, be viewed with caution until 
further research has evaluated the efficacy of  NaHCO3 
with normoxic and hypoxic comparators.
Despite this assertion and the ergogenic outcomes 
found in the current study, a number of previous investi-
gations have not reported similar performance-enhancing 
properties of  NaHCO3 under acute moderate hypoxic con-
ditions (Saunders et al. 2014a; Flinn et al. 2014). Flinn 
et  al. (2014) performed a similar exhaustive intermit-
tent exercise protocol to the present study, but utilised 
a supra-maximal exercise intensity under acute hypoxic 
conditions; while Saunders et al. (2014a) used a repeated 
sprint protocol prolonged across 90 min to simulate soccer 
performance, and found no positive performance effect. 
This discrepancy between the current study and prior 
research could be attributed to the timing of administer-
ing  NaHCO3, since both Saunders et al. (2014a) and Flinn 
et al. (2014) used a gelatine capsule delivery method over 
a 4-h and 90-min period prior to exercise, respectively. In 
contrast, the current study accounted for the individual 
temporal characteristics of acid–base kinetics following 
 NaHCO3 supplementation, by ensuring participants com-
menced exercise tests at the peak blood  [HCO3−], to max-
imise buffering potential (Jones et al. 2016; Gough et al. 
2017). Indeed, the time course to peak blood  [HCO3−] 
using a gelatine capsule has previously been shown to 
range from 75 to 180 min and a median of 120 min in 
a similar participant cohort; while the range from liquid 
supplementation was between 40 and 90 min in the pre-
sent study. However, when comparing pre-exercise blood 
 [HCO3−] between current and previous studies it is not 
clear that utilising an individualised strategy is superior 
at maximising the ergogenic effect of  NaHCO3. The cur-
rent study reported a mean 6.9 mmol l−1(g = 3.5, 95% CI 
2.1–5.0) increase in blood  [HCO3−] compared to placebo, 
which is greater than the 5.7 mmol l−1 (g = 3.4, 95% CI 
2.9–3.8) increase reported by Saunders et al. (2014a) but 
Flinn et al. (2014) reported a greater 7.6 mmol l−1 (g = 4.4, 
95% CI 3.7–5.0) increase; despite showing no positive per-
formance effect. Interestingly, the standardised effect sizes 
and corresponding 95% confidence intervals suggest the 
effect on pre-exercise  [HCO3−] was similar between inves-
tigations as the confidence intervals overlap. Therefore, 
while an individualised supplementation strategy may be 
appropriate to maximised blood  [HCO3−] prior to exercise 
within individuals (Jones et al. 2016; Gough et al. 2017); 
timing may not be the only residing factor that determines 
the ergogenicity of  NaHCO3 supplementation. Further 
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research is therefore required to determine the efficacy 
of individualised timing against a standardised timing 
strategy.
Despite the contemporary development of personalised 
 NaHCO3 supplementation ingestion time, the adverse gas-
trointestinal (GI) side effects remain apparent. As evident 
in participant 9 (Fig. 2), who experienced substantial GI 
complaints, the side effects of supplementation may pro-
duce an ergolytic performance effect. Previous research sug-
gests that the variability in  NaHCO3 ergogenic properties 
may be dependent on presence and severity of GI symp-
toms (Saunders et al. 2014b). However, GI complaints and 
a negative or no performance effect are not always apparent, 
as the ergogenic and adverse effects of  NaHCO3 have been 
shown to coexist (McNaughton et al. 2016), with Cameron 
et al. (2010) reporting a weak association between the two 
parameters (r = 0.35; p = 0.09). Given this lack of clarity 
in this relationship and the failure of the current study to 
empirically quantify GI complaints, the negative influence 
of  NaHCO3 can only be inferred in this study as it provides 
little direct evidence to support the notion that GI complaints 
from  NaHCO3 supplementation can impair exercise perfor-
mance or lessen the ergogenic effects.
Independent of individual exercise performance 
effects, the temporal blood acid–base behaviour following 
 NaHCO3 supplementation and exhaustive exercise, were 
comparable to the wider literature base (Carr et al. <link 
rid="bib9">2011</link; Flinn et al. 2014; Saunders et al. 
2014a; Deb et al. 2017). Oral  NaHCO3 supplementation 
induced peak blood  [HCO3−] concentrations that are greater 
than 6 mmol l−1 compared to placebo, which is above the 
suggested level required for  NaHCO3 to exhibit an ergo-
genic effect (Carr et al. 2011). The change in blood pH and 
 [HCO3−] was greater during exercise with  NaHCO3 com-
pared to placebo, with an equivalent larger rise in blood [lac-
tate] during the  NaHCO3 experimental trial. Indeed, there is 
evidence to suggest  NaHCO3 promotes non-oxidative energy 
metabolism, as observed through greater muscle lactate pro-
duction, and muscle glycogen utilisation during intermittent 
exercise performed in the severe-intensity domain (Percival 
et al. 2015). Despite not measuring muscle glycogen utilisa-
tion or muscle lactate production in the current study, based 
on previous research it is appropriate to speculate that the 
observed ergogenic effects of  NaHCO3 may be mediated 
through augmenting glycolytic bioenergetic contribution, 
and an enhanced muscle glycogen utilisation. While this is 
a plausible theory, it is important to highlight that the rise 
in blood [lactate] during the treatment condition may be 
explained by a reduction lactate uptake into inactive mus-
cle tissue (Granier et al. 1996) and/or an increase in lactate 
efflux from intramuscular to extracellular regions (Bishop 
et al. 2004) following  NaHCO3 supplementation. As such, 
an increase in glycolytic activity can only be speculated in 
the current investigation. In addition, it is also prudent to 
highlight that pH at the end of exercise did not reach com-
parable values in the experimental and placebo trials, which 
conforms with previous research (Carr et al. 2011). This 
suggests that pH may not be the solitary reason for exercise 
termination in the experimental condition. Given the multi-
faceted nature of fatigue alternative explanations may exist; 
such as the strong ion difference, which refers to the intra- 
and extracellular ions (e.g. potassium, sodium, chloride) 
that are involved in skeletal muscle contraction. Evidence 
suggests  NaHCO3 can alter the ionic charge of these com-
partments by attenuating the efflux of potassium ions from 
the musculature and therefore, maintaining muscle contrac-
tile properties during exercise (Siegler et al. 2016). Muscle 
potassium concentrations were however, not measured in the 
current study and consequently its role in this context can 
only be speculated. The SID also has an independent effect 
on pH (Stewart 1978), and thus it may exert skeletal mus-
cle performance impairing effects through altering intra- or 
extra-cellular pH. Further research is required to understand 
the alternative reasons for exercise termination in the experi-
mental condition despite pH remaining elevated; this may 
include assessing the function of the strong ion difference.
It is prudent to highlight the diversity in training status 
of the participant cohort as both trained and recreationally 
active individuals volunteered for this study. This does not 
however, limit the applicability of our findings given the 
wide-ranging applications of acute hypoxic training meth-
ods, from trained athletes (Faiss et al. 2013), healthy indi-
viduals (Shatilo et al. 2008) to patient cohorts (Millet et al. 
2016). Consequently, further research investigating the 
effects of  NaHCO3 as a training aid during acute hypoxic 
training programs in a range of population may be benefi-
cial. In addition, a limitation to the application of this study 
may be in the environment at which  NaHCO3 was ingested; 
in that, ingesting  NaHCO3 whilst remaining under acute 
hypoxic conditions prior to exercise may have altered the 
outcomes of the study as opposed to the ingestion under 
normoxic conditions in this study. Indeed, exposure to 
hypoxic conditions is suggested to diminish blood  [HCO3−] 
(Cerretelli and Samaja 2003) and therefore, prolonged prior 
hypoxic exposure may have perturbed the manipulation of 
the acid–base balance following  NaHCO3 ingestion. This 
however, can only be hypothesised until further experimental 
work investigates the temporal acid–base response following 
 NaHCO3 under acute hypoxic conditions and the subsequent 
impact on exercise performance. Nevertheless, this study is 
the first to demonstrate  NaHCO3 supplementation in nor-
moxic conditions can improve severe-intensity intermittent 
exercise performance under acute moderate hypoxic condi-
tions. Therefore, providing a potential ergogenic strategy 
for individuals undertaking acute hypoxic exercise bouts 
as part of training programme. Furthermore, this study 
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demonstrates that ingesting  NaHCO3 at a pre-determined 
peak blood  [HCO3−] prior to commencing exercise is an 
efficacious method to enhance blood  HCO3− buffering 
potential. However, caution should be taken as the adverse 
GI complaints associated with  NaHCO3 may produce ergo-
lytic effects. To build on the current investigation, further 
empirical research should consider the use of  NaHCO3 as a 
training aid during hypoxic training strategies, to determine 
if repeated acute supplementation prior to exercise alters the 
molecular training adaptations associated with intermittent 
acute hypoxic training.
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